133 filings
8-K
TPST
Tempest Therapeutics Inc
19 Mar 24
Tempest Reports Year End 2023 Financial Results and Provides Business Update
4:10pm
8-K
TPST
Tempest Therapeutics Inc
8 Nov 23
Tempest Reports Third Quarter 2023 Financial Results and Provides Business Update
5:18pm
8-K
TPST
Tempest Therapeutics Inc
30 Oct 23
Other Events
6:06am
8-K
TPST
Tempest Therapeutics Inc
11 Oct 23
Entry into a Material Definitive Agreement
8:13am
8-K
TPST
Tempest Therapeutics Inc
8 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:16pm
8-K
ilvc8 2pg1
7 Sep 23
Departure of Directors or Certain Officers
4:19pm
8-K
kturlowe6iha
10 Aug 23
Tempest Reports Second Quarter 2023 Financial Results and Provides Business Update
4:27pm
8-K
qve hvyicah
16 Jun 23
Departure of Directors or Certain Officers
4:22pm
8-K
aattfqs xfd
10 May 23
Tempest Reports First Quarter 2023 Financial Results and Provides Business Update
4:21pm
8-K
ma2x1s9
28 Apr 23
Tempest Announces Positive Early Results from Global Randomized Phase 1b/2 Combination Study of TPST-1120 in First-Line Hepatocellular Carcinoma
8:30am
8-K
trsaba5i 1fu
31 Mar 23
Other Events
5:07pm
8-K
rx1 txcv4
22 Mar 23
Tempest Reports Year End 2022 Financial Results and Provides
5:27pm
8-K
j790eoau3hy
29 Dec 22
Entry into a Material Definitive Agreement
4:06pm
8-K
e74re t42drul3
8 Nov 22
Tempest Reports Third Quarter 2022 Financial Results and Provides Business Update
8:55am
8-K
du0c 7ebt
23 Sep 22
Departure of Directors or Certain Officers
4:06pm
8-K
3jmgee2hu
15 Aug 22
Tempest Reports Second Quarter 2022 Financial Results and Provides Business Update
8:05am
8-K
vr34mcznheq
21 Jun 22
Departure of Directors or Certain Officers
7:31am
8-K
7c097 6wkq476s
9 Jun 22
Tempest Provides ASCO KOL Feedback on TPST-1120 Clinical Results and Updated Financial Guidance
8:08am
8-K
nu4 bgx9f
26 May 22
Tempest Reports Positive TPST-1120 Clinical Data from Phase 1 Trial in Patients with Advanced Solid Tumors at 2022 ASCO Annual Meeting
5:06pm
8-K
t1qbdt6p1yl1kf k7v52
13 May 22
Tempest Reports First Quarter 2022 Financial Results and Provides Corporate Highlights
8:03am